Vanda Pharmaceuticals Inc (VNDA) - Financial and Strategic SWOT Analysis Review

Vanda Pharmaceuticals Inc (VNDA) - Financial and Strategic SWOT Analysis Review

- provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:
  • Business description – A detailed description of the company’s operations and business divisions.
  • Corporate strategy – Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history – Progression of key events associated with the company.
  • Major products and services – A list of major products, services and brands of the company.
  • Key competitors – A list of key competitors to the company.
  • Key employees – A list of the key executives of the company.
  • Executive biographies – A brief summary of the executives’ employment history.
  • Key operational heads – A list of personnel heading key departments/functions.
  • Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
  • Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights

Vanda Pharmaceuticals Inc (Vanda) is a biopharmaceutical company that develops and commercializes novel therapies for the treatment of central nervous system disorders. The company’s products include Hetlioz, a melatonin receptor agonist for the treatment of non-24-hour sleep-wake disorder; Ponvory for the treatment of relapsing forms of multiple sclerosis; and Fanapt, a typical antipsychotic for the treatment of schizophrenia in adults. The company’s major pipeline products include Tradipitant (VLY-686), VTR-297, VQW-765, CFTR and a portfolio of cystic fibrosis transmembrane conductance regulator inhibitors and activators. Vanda is headquartered in Washington, Washington DC, the US.

Vanda Pharmaceuticals Inc Key Recent Developments

Nov 06,2024: Vanda Pharmaceuticals Reports Third Quarter 2024 Financial Results
Jul 31,2024: Vanda Pharmaceuticals Releases Q2 2024 Results
Jul 26,2024: Vanda Pharmaceuticals to Announce Second Quarter 2024 Financial Results on July 31, 2024
May 29,2024: Vanda Pharmaceuticals Announces Presentations at SLEEP 2024

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note:Some sections may be missing if data is unavailable for the company


Section 1 - About the Company
Vanda Pharmaceuticals Inc - Key Facts
Vanda Pharmaceuticals Inc - Key Employees
Vanda Pharmaceuticals Inc - Key Employee Biographies
Vanda Pharmaceuticals Inc - Major Products and Services
Vanda Pharmaceuticals Inc - History
Vanda Pharmaceuticals Inc - Company Statement
Vanda Pharmaceuticals Inc - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
Vanda Pharmaceuticals Inc - Business Description
R&D Overview
Vanda Pharmaceuticals Inc - Corporate Strategy
Vanda Pharmaceuticals Inc - SWOT Analysis
SWOT Analysis - Overview
Vanda Pharmaceuticals Inc - Strengths
Vanda Pharmaceuticals Inc - Weaknesses
Vanda Pharmaceuticals Inc - Opportunities
Vanda Pharmaceuticals Inc - Threats
Vanda Pharmaceuticals Inc - Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
Vanda Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2018 to YTD 2024
Vanda Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Type, 2018 to YTD 2024
Vanda Pharmaceuticals Inc, Recent Deals Summary
Section 5 – Company’s Recent Developments
Nov 06, 2024: Vanda Pharmaceuticals Reports Third Quarter 2024 Financial Results
Jul 31, 2024: Vanda Pharmaceuticals Releases Q2 2024 Results
Jul 26, 2024: Vanda Pharmaceuticals to Announce Second Quarter 2024 Financial Results on July 31, 2024
May 29, 2024: Vanda Pharmaceuticals Announces Presentations at SLEEP 2024
May 24, 2024: Vanda Pharmaceuticals Board of Directors Determines that Revised Unsolicited Takeover Proposal is Not in the Best Interests of the Company and its Shareholders
May 08, 2024: Vanda Pharmaceuticals Reports First Quarter 2024 Financial Results
Feb 07, 2024: Vanda Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results
Jan 19, 2024: Federal Court Allows Vanda Pharmaceuticals' Lawsuit to Proceed Against the U.S. Food and Drug Administration
Jan 12, 2024: Vanda Pharmaceuticals Comments on FDA's Recently Announced Guidance on Communication with Health Care Professionals Regarding FDA-Approved Drugs
Dec 08, 2023: Vanda acquires rights to Actelion’s multiple sclerosis drug
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer
List of Tables
Vanda Pharmaceuticals Inc, Key Facts
Vanda Pharmaceuticals Inc, Key Employees
Vanda Pharmaceuticals Inc, Key Employee Biographies
Vanda Pharmaceuticals Inc, Major Products and Services
Vanda Pharmaceuticals Inc, History
Vanda Pharmaceuticals Inc, Subsidiaries
Vanda Pharmaceuticals Inc, Key Competitors
Vanda Pharmaceuticals Inc, Ratios based on current share price
Vanda Pharmaceuticals Inc, Annual Ratios
Vanda Pharmaceuticals Inc, Annual Ratios (Cont...1)
Vanda Pharmaceuticals Inc, Annual Ratios (Cont...2)
Vanda Pharmaceuticals Inc, Interim Ratios
Vanda Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2018 to YTD 2024
Vanda Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Type, 2018 to YTD 2024
Vanda Pharmaceuticals Inc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios
List of Figures
Vanda Pharmaceuticals Inc, Performance Chart (2019 - 2023)
Vanda Pharmaceuticals Inc, Ratio Charts
Vanda Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2018 to YTD 2024
Vanda Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals by Type, 2018 to YTD 2024

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings